We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Breast Density Not Linked to Cancer Incidence

By HospiMedica International staff writers
Posted on 21 Dec 2015
Print article
A new study suggests that breast density may not actually be a strong predictor of cancer risk after all.

Researchers at Health Center Osijek (Croatia) conducted a retrospective study involving 52,962 mammography exams performed in women aged 50–69 over a period of five years at five different mammography facilities in the vicinity of Osijek (Croatia). Two radiologists read the mammograms independently and determined breast density according to standard criteria. The researchers then compared data between patients in the low-density breast tissue group and the high-density group.

The researchers found that the majority of screened women had low breast density. Of the 230 women with detected breast cancers, almost half were from the group with the lowest-ranked breast density, while slightly less than 3% came from women in the highest breast density category. When the researchers matched the women who had a detected cancer with control participants of the same age and from the same locales that did not have cancer, they found no significant difference in mammographic density.

Women with low mammographic density made up 83% of the patients in the breast cancer group, compared with 89% in the control group, while high mammographic density was found in 17% of the breast cancer patients and 11% of women in the control group. The study also failed to find a strong association between higher mammographic densities and a higher risk of breast cancer among postmenopausal women. The study was presented at the Radiological Society of North America (RSNA) annual meeting, held during November-December 2015 in Chicago (IL, USA).

“We wanted to find out if breast cancer patients had more dense breast tissue than the healthy women. Also, we wanted to see what the percentage of dense breasts was in our postmenopausal population and, consequently, determine the value of mammography screening for this group,” said lead author and study presenter Natasa Katavic, MD, of the department of radiology. “We found that there was no significant difference in breast density between breast cancer patients and the control group in the screening program.”

Prior research has suggested an association between breast density and breast cancer; in addition, cancers in dense breast tissue are more difficult to see on mammograms. As a result, some women with dense breasts are advised to get supplementary screening with ultrasound or magnetic resonance imaging (MRI).

Related Links:

Health Center Osijek


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Pre-Op Planning Solution
Sectra 3D Trauma

Print article

Channels

Surgical Techniques

view channel
Image: LUMISIGHT and Lumicell DVS offer 84% diagnostic accuracy in detecting residual cancer (Photo courtesy of Lumicell)

Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery

Breast cancer is becoming increasingly common, with statistics indicating that 1 in 8 women will develop the disease in their lifetime. Lumpectomy remains the predominant surgical intervention for treating... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.